Yvette L Kasamon

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Mona Elmacken, Helkha Peredo-Pinto, Cong Wang, Zhenzhen Xu, Million A Tegenge, Adnan A Jaigirdar, Marc R Theoret, Tejashri Purohit-Sheth, Yvette L Kasamon
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mona Elmacken, Helkha Peredo-Pinto, Cong Wang, Zhenzhen Xu, Million A Tegenge, Adnan A Jaigirdar, Marc R Theoret, Tejashri Purohit-Sheth, Yvette L Kasamon
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Mona Elmacken, Helkha Peredo-Pinto, Cong Wang, Zhenzhen Xu, Million A Tegenge, Adnan A Jaigirdar, Marc R Theoret, Tejashri Purohit-Sheth, Yvette L Kasamon
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon, Rachel Ershler, Emily Y Jen, Bindu Kanapuru, Nicholas C Richardson, Ashley Lane, Theresa Carioti, Marc R Theoret, Richard Pazdur, Nicole J Gormley
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Poornima Sharma, Yvette L Kasamon, Xue Lin, Zhenzhen Xu, Marc R Theoret, Tejashri Purohit-Sheth
FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Deepti Telaraja, Yvette L Kasamon, Justin S Collazo, Ruby Leong, Kun Wang, Ping Li, Elyes Dahmane, Yuching Yang, Justin Earp, Manuela Grimstein, Lisa R Rodriguez, Marc R Theoret, Nicole J Gormley
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)